InvestSMART

Recce Pharmaceuticals Ltd (ASX: RCE) - Announcements

Current share price for RCE : $0.370 0.005 (1.33%)+

ASX company news and announcements for Recce Pharmaceuticals Ltd (RCE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Recce Pharmaceuticals Ltd (RCE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Recce Pharmaceuticals Ltd (RCE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Recce Pharmaceuticals Ltd (RCE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$113 Successful Share Purchase Plan 23 Oct 2017 12:35PM $0.185 $0.370 risen by 100%
$113 Notice of Annual General Meeting/Proxy Form 20 Oct 2017 3:26PM $0.185 $0.370 risen by 100%
$113 Appendix 4G 20 Oct 2017 3:17PM $0.185 $0.370 risen by 100%
$113 Annual Report to shareholders 20 Oct 2017 3:14PM $0.185 $0.370 risen by 100%
$113 Cleansing Statement 3 Oct 2017 1:54PM $0.185 $0.370 risen by 100%
$113 Appendix 3B 3 Oct 2017 1:51PM $0.185 $0.370 risen by 100%
$113 Recce Launches Share Purchase Plan 27 Sep 2017 12:38PM $0.215 $0.370 risen by 72.09%
$113 Correction to Appendix 3B 26 Sep 2017 2:01PM $0.220 $0.370 risen by 68.18%
$113 Cleansing Statement 25 Sep 2017 2:44PM $0.220 $0.370 risen by 68.18%
$113 Appendix 3B 25 Sep 2017 2:40PM $0.220 $0.370 risen by 68.18%
$113 Response to ASX Price Query 18 Sep 2017 1:36PM $0.230 $0.370 risen by 60.87%
$113 Investor Presention 15 Sep 2017 1:03PM $0.140 $0.370 risen by 164.29%
$113 Cleansing Statement 7 Sep 2017 6:50PM $0.165 $0.370 risen by 124.24%
$113 Appendix 3B 7 Sep 2017 6:48PM $0.165 $0.370 risen by 124.24%
$113 Recce Confirms Pre-IND Data Submission to US FDA 7 Sep 2017 9:34AM $0.165 $0.370 risen by 124.24%
$113 Appendix 4E and Financial Report 1 Sep 2017 8:16AM $0.160 $0.370 risen by 131.25%
$113 Appendix 4C - quarterly 31 Jul 2017 3:44PM $0.180 $0.370 risen by 105.56%
$113 Recce Confirms Delivery by Intravenous Drip 31 Jul 2017 9:26AM $0.170 $0.370 risen by 117.65%
$113 Cleansing Statement 20 Jul 2017 5:47PM $0.180 $0.370 risen by 105.56%
$113 Appendix 3B 20 Jul 2017 5:46PM $0.180 $0.370 risen by 105.56%
$113 Recce achieves milestone with volume production 20 Jul 2017 9:06AM $0.180 $0.370 risen by 105.56%
$113 Cleansing Statement 22 Jun 2017 1:26PM $0.230 $0.370 risen by 60.87%
$113 Appendix 3B 22 Jun 2017 1:24PM $0.230 $0.370 risen by 60.87%
$113 Recce constructs automated manufacturing facility to support 22 Jun 2017 10:11AM $0.230 $0.370 risen by 60.87%
$113 Recce secures up to A$6.05 million investment agreement with 16 Jun 2017 10:19AM $0.200 $0.370 risen by 85%

601 - 625 of 724 results

Page 25 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.